Imaging efficacy of a hepatocyte-selective polyiodinated triglyceride for contrast-enhanced computed tomography

American Journal of Therapeutics

Volumn 8, Issue 5, 2001, Pages 359-365

  Bakan, Douglas A ^a  

^a Molecular Biosystems Inc   (United States)

Author keywords

Contrast agents; DHOG LE; Hepatic CT imaging; Hepatocyte selective; Targeted delivery

Indexed keywords

2 OLEOYLGLYCEROL 1,3 BIS(7 (3 AMINO 2,4 6 TRIIODOPHENYL)HEPTANOATE); 2-OLEOYLGLYCEROL-1,3-BIS(7-(3-AMINO-2,4-6-TRIIODOPHENYL)HEPTANOATE); CONTRAST MEDIUM; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; FEMALE; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; LIVER; METHODOLOGY; RADIOGRAPHY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAVENOUS; LIVER; RADIOGRAPHIC IMAGE ENHANCEMENT; RATS; RATS, SPRAGUE-DAWLEY; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES;

EID: 0035461102     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200109000-00009     Document Type: Article

References (5)

1. Freeman LM, Lan JA: Radiopharmaceutical evaluation of the hepatobiliary pathway. Nucl Med Biol 1990;17: 129-139.
2. Ridley EL: Liver-specific MR contrast sets up challenge with CT; FDA approves iron-oxide-based product. Diagnostic Imaging 1996;18:13-15.
3. Saini S, Edelman RR, Li W, et al: Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging. Acad Radiol 1996;3:409-412.
4. Schmitz SA, Muhler.A, Wagner S, et al: Functional hepatobiliary imaging with gadolinium-EOB-DTPA: a comparison of magnetic resonance imaging and gadoliniumEOB-DTPA scintigraphy in rats. Invest Radiol 1996;31: 154-160.
5. Schuhmann-Giampieri G, Mahler M, Roll G, et al: Pharmacokinetics of the liver-specific contrast agent GdEOB-DTPA in relation to contrast-enhanced liver imaging in humans. J Clin Pharmacol 1997;37:587-596.